India to take in the fight against Corona drastic measures: raw materials are to remain in the country, drugs shortage.
MUMBAI taz | Even though in the metropolis of Mumbai, the hand sanitizer is running low bear, the fear of lung disease Covid-19 so far in India is relatively low. More people with breathing masks are to international fairs to see, but the number of confirmed cases remains low: 28 people are officially sick of the Coronavirus, including 15 tourists from Italy.
Nevertheless, India is taking harsh measures: at the beginning of the week, the authorities decided that the Export of 26 drugs and active substances, including antibiotics, vitamins and hormones, restrict. Paracetamol and Vitamin B1, B6, B 12, for example, are listed on the list.
The Indian pharmaceutical market is the world's largest for generic drugs, the cheaper "generic drugs". The German company Stada, Hexal, Ratiopharm, but also the Swiss pharmaceutical group Novartis, among other things, India can produce. Germany is one of the largest importers of Indian generic medicines in the EU and could be affected by the export restrictions.
The decision was made due to a recommendation from the pharmaceutical Department and to limit bottlenecks in India. So important base materials are to remain in the country to a medication shortage. According to the newspaper, Economic Times of India referred to the last more than 60 percent of its drugs, and precursors from China. In addition to the export restriction on visas for Italy, Iran, Korea, and Japan have been suspended to India. In the future, all passengers coming from international flights to India should be checked on arrival at Covid-19 symptoms, it was the part of the Ministry of health.Date Of Update: 05 March 2020, 16:00